Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2012
07/18/2012CN102579328A Pharmaceutical composition for injection
07/18/2012CN102579324A Application of levetiracetam injection in preparation of nootropic drugs
07/18/2012CN102579320A Citicoline sodium brain-targeting thermosensitive gel and preparation method thereof
07/18/2012CN102382082B Novel potassium sodium dehydroandroan drographolide succinate compound and drug combination thereof
07/18/2012CN102188654B Traditional Chinese medicine composition for treating multiple neurofibromatosis
07/18/2012CN102166341B Preparation method of Xiaoyao powder antidepressant extract
07/18/2012CN102114229B Traditional Chinese medicine preparation for treating schizophrenia
07/18/2012CN102091105B New application of field pennycress and preparation thereof
07/18/2012CN102058637B Preparation method of patrimia scabiosaefolia extract
07/18/2012CN102048857B Method for extracting alkaloid from Kratom
07/18/2012CN102028767B Traditional Chinese medicine for treating dermatitis and preparation method thereof
07/18/2012CN101991785B Lonicerae and Forsythiae detoxication soft capsule medicine and preparation method and quality detection method thereof
07/18/2012CN101966146B Medicinal composition solution and preparation method and use thereof
07/18/2012CN101904824B Olanzapine orally-disintegrating tablet preparation and preparation method thereof
07/18/2012CN101880283B Azaindole kinase inhibitors
07/18/2012CN101843630B Composite containing iridoid compound and application thereof
07/18/2012CN101837091B Process for continuously extracting polygonatum saponin and polygonatum polysaccharose
07/18/2012CN101805390B Tripterine derivate and use thereof
07/18/2012CN101723942B Method for preparing imide derivatives
07/18/2012CN101721511B Medicine combination for treating headache or migraine and preparation method thereof
07/18/2012CN101658544B Controlled release tablets of huperzia serrata and method for preparing same
07/18/2012CN101595098B 1,2,4-triazole derivatives as sigma receptor inhibitors
07/18/2012CN101554210B A process for decreasing environmental pollutants in an oil or a fat, use of processing fluid and marine oil product
07/18/2012CN101531717B Anti-Alzheimer disease monoclonal antibody and application thereof
07/18/2012CN101528261B Pharmaceutical compositions of clonazepam and methods of use thereof
07/18/2012CN101524375B Wet-process wall breaking method of lucidum spore powder
07/18/2012CN101516881B 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
07/18/2012CN101502601B Chinese medicinal composition for Alzheimer's symptoms and preparation method thereof
07/18/2012CN101501038B Fused [d]pyridazin-7-ones
07/18/2012CN101490012B Novel crystal of substituted phenylalkanoic acid and production process
07/18/2012CN101486743B Novel iridoid compound with anti-Alzheimer's disease function
07/18/2012CN101466676B Pyridyl amide T-type calcium channel antagonists
07/18/2012CN101463019B Amidine compounds containing aryl, arylmethyl and piperazinyl
07/18/2012CN101455698B Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory
07/18/2012CN101440124B Methods for preventing mitochondrial permeability transition
07/18/2012CN101428021B Externally used medicament preparation for quitting tobacco and wine
07/18/2012CN101401854B Medicament formulation for treating epilepsy and preparation thereof
07/18/2012CN101396416B Medicine composition for prenatal and postnatal care and preventing the birth defect and improving the memory
07/18/2012CN101395139B Sigma receptor compounds
07/18/2012CN101378750B Indolone compounds useful to treat cognitive impairment
07/18/2012CN101375913B Pharmaceutical combination for preventing birth-defect and improving memory
07/18/2012CN101375907B Pharmaceutical combination for preventing birth-defect and improving memory
07/18/2012CN101371826B Percutaneous absorption patch
07/18/2012CN101366862B Medicament composition for preventing birth defect and improving memory
07/18/2012CN101366840B Medicament composition for preventing birth defection and improving memory
07/18/2012CN101366812B Medicament composition for preventing birth defection and improving memory
07/18/2012CN101366775B Medicament composition for preventing birth defection and improving memory
07/18/2012CN101366756B Pharmaceutical combination for preventing birth defect and improving anamnesis
07/18/2012CN101366754B Pharmaceutical combination for preventing birth defect and improving anamnesis
07/18/2012CN101366742B Medicament composition for preventing birth defect and improving memory
07/18/2012CN101328166B 2-dihydroindole ketone derivate as protein kinase inhibitor and histone deacetylase inhibitor
07/18/2012CN101176742B Preparation method of pharmaceutical composition for curing cough
07/18/2012CN101146775B Metabolites for nk-i antagonists for emesis
07/17/2012US8222277 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/17/2012US8222258 Stable pharmaceutical composition of freeze-dried tetrodoxin powder
07/17/2012US8222212 Prolactin induced increase in neural stem cell numbers
07/17/2012US8222002 Human anti-amyloid beta peptide antibody and fragment of said antibody
07/17/2012US8221790 Therapeutic polyesters and polyamides
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012CA2718348C Orally administered peptides to ameliorate atherosclerosis
07/17/2012CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates
07/17/2012CA2679973C Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment
07/17/2012CA2559683C Use of rotigotine for treating and preventing parkinson's plus syndrome
07/17/2012CA2492659C 6-(3-pyridyl-methylamino)purine derivatives and their use as antiproliferative agents
07/17/2012CA2488373C N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris
07/17/2012CA2482002C Curcumin analogues and uses thereof
07/17/2012CA2451028C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/17/2012CA2446201C Improved neuronal gene transfer
07/17/2012CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof
07/12/2012WO2012094636A2 Chemosensory receptor ligand-based therapies
07/12/2012WO2012094081A2 System and method for identifying and applying peripheral treatment mechanisms for disease
07/12/2012WO2012093787A2 Composition for activating gabaa benzodiazepine receptor and composition for anxiety alleviation, convulsion reduction, sedation and sleep induction and improvement containing phloroglucinol, phlorotannin or brown algae extract
07/12/2012WO2012093255A1 Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy
07/12/2012WO2012093169A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
07/12/2012WO2012093148A1 Fused aminodihydrothiazine derivatives
07/12/2012WO2012093127A2 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease
07/12/2012WO2012093109A1 Pyrrolidine derivatives as nk3 antagonists
07/12/2012WO2012068516A3 Low dose cannabinoid medicaments
07/12/2012WO2012065110A3 S-protected cysteine analogs and related compounds
07/12/2012WO2012062925A3 Compounds and methods for treating pain
07/12/2012WO2007079840A9 Benzochromene derivatives
07/12/2012US20120178820 Method for treating arthritis
07/12/2012US20120178815 Compositions of (-)-E-10-OH-NT and Methods for Their Synthesis and Use
07/12/2012US20120178811 Method of using beta-hydroxy-beta-methylbutyrate to reduce the risk of infection in an elderly individual
07/12/2012US20120178810 Extended release formulation of an antiepileptic agent
07/12/2012US20120178809 Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof
07/12/2012US20120178797 Novel therapeutic and diagnostic products and methods
07/12/2012US20120178792 Drg11-responsive (dragon) gene family
07/12/2012US20120178790 Crystalline form of a 3-phenoxymethylpyrrolidine compound
07/12/2012US20120178789 Novel pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
07/12/2012US20120178785 Derivatives of n-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators
07/12/2012US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System
07/12/2012US20120178781 Kappa opioid receptor ligands
07/12/2012US20120178778 Pyrazolopyridines
07/12/2012US20120178776 Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mglur5 modulators
07/12/2012US20120178775 Methods for treating frontotemporal lobar degeneration with ubiquitinated inclusions (ftld-u)
07/12/2012US20120178774 Toll-like receptor modulators and uses thereof
07/12/2012US20120178773 Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
07/12/2012US20120178772 Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
07/12/2012US20120178766 Furopyrimidinedione derivatives as trpai modulators